You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer
Molecular Cancer, January 2014
Kelie M Reece, Emily D Richardson, Kristina M Cook, Tessa J Campbell, Stephen T Pisle, Alesia J Holly, David J Venzon, David J Liewehr, Cindy H Chau, Douglas K Price, William D Figg
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||10||32%|
|Student > Bachelor||4||13%|
|Student > Master||3||10%|
|Readers by discipline||Count||As %|
|Agricultural and Biological Sciences||8||26%|
|Medicine and Dentistry||7||23%|
|Biochemistry, Genetics and Molecular Biology||6||19%|
|Nursing and Health Professions||1||3%|